Pmv Pharmaceuticalsinc Stock Today
| PMVP Stock | USD 1.64 0.15 8.38% |
Performance0 of 100
| Odds Of DistressOver 55
|
Pmv PharmaceuticalsI is selling at 1.64 as of the 16th of April 2024; that is -8.38% down since the beginning of the trading day. The stock's last reported lowest price was 1.61. Pmv PharmaceuticalsI has over 55 % chance of experiencing financial distress in the next 2 years of operation and has generated negative returns for investors over the last 90 days. Equity ratings for Pmv PharmaceuticalsInc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of April 2022 and ending today, the 16th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 25th of September 2020 | Category Healthcare | Classification Health Care |
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey. The company has 51.44 M outstanding shares of which 2.6 M shares are at this time shorted by private and institutional investors with about 3.73 trading days to cover. More on Pmv PharmaceuticalsInc
Moving against Pmv Stock
| 0.59 | EWTX | Edgewise Therapeutics Financial Report 9th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 8th of May 2024
Pmv Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pmv PharmaceuticalsI's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pmv PharmaceuticalsI or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Health Care, NASDAQ Composite, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Pmv PharmaceuticalsI report their recommendations after researching Pmv PharmaceuticalsI's financial statements, talking to executives and customers, or listening in on Pmv PharmaceuticalsI's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Pmv PharmaceuticalsInc. The Pmv consensus assessment is calculated by taking the average forecast from all of the analysts covering Pmv PharmaceuticalsI. | ||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators obtained from Pmv PharmaceuticalsI's historical financial statements, Pmv PharmaceuticalsInc is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Pmv PharmaceuticalsInc is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||
Pmv PharmaceuticalsI's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Pmv PharmaceuticalsI's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Pmv PharmaceuticalsI's financial leverage. It provides some insight into what part of Pmv PharmaceuticalsI's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Pmv PharmaceuticalsInc (PMVP) is traded on NASDAQ Exchange in USA. It is located in 1 Research Way, Princeton, NJ, United States, 08540 and employs 63 people. Pmv PharmaceuticalsI is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 92.08 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pmv PharmaceuticalsI's market, we take the total number of its shares issued and multiply it by Pmv PharmaceuticalsI's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pmv PharmaceuticalsInc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 51.44 M outstanding shares of which 2.6 M shares are at this time shorted by private and institutional investors with about 3.73 trading days to cover.
Pmv PharmaceuticalsInc currently holds about 277.43 M in cash with (55.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Pmv PharmaceuticalsI Probability Of Bankruptcy
Ownership AllocationPmv PharmaceuticalsInc has a total of 51.44 Million outstanding shares. The majority of Pmv PharmaceuticalsInc outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Pmv PharmaceuticalsInc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Pmv PharmaceuticalsI. Please pay attention to any change in the institutional holdings of Pmv PharmaceuticalsInc as this could imply that something significant has changed or is about to change at the company. Also note that almost one million twenty-eight thousand eight hundred seventy invesors are currently shorting Pmv PharmaceuticalsI expressing very little confidence in its future performance.
Check Pmv Ownership Details
Pmv Stock Price Odds Analysis
In regard to a normal probability distribution, the odds of Pmv PharmaceuticalsI jumping above the current price in 90 days from now is about 71.07%. The Pmv PharmaceuticalsInc probability density function shows the probability of Pmv PharmaceuticalsI stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Pmv PharmaceuticalsI has a beta of 0.9176 indicating Pmv PharmaceuticalsInc market returns are sensible to returns on the market. As the market goes up or down, Pmv PharmaceuticalsI is expected to follow. Additionally, pmv PharmaceuticalsInc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Pmv PharmaceuticalsI to move above the current price in 90 days from now is about 71.07 (This Pmv PharmaceuticalsInc probability density function shows the probability of Pmv Stock to fall within a particular range of prices over 90 days) .
Pmv Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Pmv PharmaceuticalsI that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Pmv PharmaceuticalsI's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Pmv PharmaceuticalsI's value.| Instituion | Recorded On | Shares | |
| Verition Fund Managegment, Llc | 2023-12-31 | 1.6 M | |
| Bank Of America Corp | 2023-12-31 | 1.4 M | |
| Partner Fund Management Lp | 2023-09-30 | 1.3 M | |
| Oup Management Co., Llc | 2023-09-30 | 989.2 K | |
| Octagon Capital Advisors Lp | 2023-09-30 | 904 K | |
| Geode Capital Management, Llc | 2023-12-31 | 860.3 K | |
| Acadian Asset Management Llc | 2023-12-31 | 768.4 K | |
| Ghost Tree Capital, Llc | 2023-12-31 | 725 K | |
| State Street Corporation | 2023-12-31 | 723.5 K | |
| Orbimed Advisors, Llc | 2023-12-31 | 6.5 M | |
| Jpmorgan Chase & Co | 2023-12-31 | 3.9 M |
Pmv PharmaceuticalsI Historical Income Statement
Pmv PharmaceuticalsInc Income Statement is one of the three primary financial statements used for reporting Pmv's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Pmv PharmaceuticalsInc revenue and expense. Pmv PharmaceuticalsI Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Pmv PharmaceuticalsI's Non Operating Income Net Other is relatively stable compared to the past year. View More FundamentalsPmv Stock Against Markets
Picking the right benchmark for Pmv PharmaceuticalsI stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Pmv PharmaceuticalsI stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Pmv PharmaceuticalsI is critical whether you are bullish or bearish towards Pmv PharmaceuticalsInc at a given time. Please also check how Pmv PharmaceuticalsI's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pmv PharmaceuticalsI without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
Pmv PharmaceuticalsI Corporate Management
Elected by the shareholders, the Pmv PharmaceuticalsI's board of directors comprises two types of representatives: Pmv PharmaceuticalsI inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pmv. The board's role is to monitor Pmv PharmaceuticalsI's management team and ensure that shareholders' interests are well served. Pmv PharmaceuticalsI's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pmv PharmaceuticalsI's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Deepika PharmD | Chief Officer | Profile | |
| Crystal Zuckerman | Vice Resources | Profile | |
| Arnold Levine | Independent CoFounder | Profile | |
| Michael Carulli | Chief Officer | Profile | |
| Leila MD | Chief Officer | Profile | |
| Binh Vu | Senior CMC | Profile | |
| Winston MBA | COO CFO | Profile |
How to buy Pmv Stock?
Before investing in Pmv PharmaceuticalsI, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Pmv PharmaceuticalsI. To buy Pmv PharmaceuticalsI stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Pmv PharmaceuticalsI. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Pmv PharmaceuticalsI stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Pmv PharmaceuticalsInc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Pmv PharmaceuticalsInc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Pmv PharmaceuticalsInc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Pmv Stock please use our How to Invest in Pmv PharmaceuticalsI guide.
Already Invested in Pmv PharmaceuticalsInc?
The danger of trading Pmv PharmaceuticalsInc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Pmv PharmaceuticalsI is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Pmv PharmaceuticalsI. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Pmv PharmaceuticalsInc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Pmv PharmaceuticalsInc is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Pmv Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Pmv Pharmaceuticalsinc Stock. Highlighted below are key reports to facilitate an investment decision about Pmv Pharmaceuticalsinc Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pmv PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Pmv Stock analysis
When running Pmv PharmaceuticalsI's price analysis, check to measure Pmv PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv PharmaceuticalsI is operating at the current time. Most of Pmv PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Pmv PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Pmv PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Pmv PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pmv PharmaceuticalsI. If investors know Pmv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pmv PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.44) | Return On Assets (0.19) | Return On Equity (0.29) |
The market value of Pmv PharmaceuticalsInc is measured differently than its book value, which is the value of Pmv that is recorded on the company's balance sheet. Investors also form their own opinion of Pmv PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Pmv PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pmv PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Pmv PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pmv PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pmv PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pmv PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.